Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients.
OBJECTIVE
Wernicke encephalopathy is a severe neurologic disorder that results from a dietary vitamin B1 deficiency. It is characterized by changes in consciousness, ocular abnormalities, and ataxia. This study was undertaken to analyze and compare findings on MR imaging and neurologic symptoms at clinical presentations of patients with Wernicke encephalopathy with and without a history of alcohol abuse.


METHODS
A multicenter study group retrospectively reviewed MR brain imaging findings, clinical histories, and presentations of 26 patients (14 female, 12 male) diagnosed between 1999 and 2006 with Wernicke encephalopathy. The age range was 6-81 years (mean age, 46 .6+/-19 years).


RESULTS
Fifty percent of the patients had a history of alcohol abuse, and 50% had no history of alcohol abuse. Eighty percent showed changes in consciousness, 77% had ocular symptoms, and 54% had ataxia. Only 38% of the patients showed the classic triad of the disease at clinical presentation. At MR examination, 85% of the patients showed symmetric lesions in the medial thalami and the periventricular region of the third ventricle, 65% in the periaqueductal area, 58% in the mamillary bodies, 38% in the tectal plate, and 8% in the dorsal medulla. Contrast enhancement of the mamillary bodies was statistically positively correlated with the alcohol abuse group.


CONCLUSIONS
Our study confirms the usefulness of MR in reaching a prompt diagnosis of Wernicke encephalopathy to avoid irreversible damage to brain tissue. Contrast enhancement in the mamillary bodies is a typical finding of the disease in the alcoholic population.
Zuccoli
G
G
Department of Radiology, Intensive Care Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy, and Magnetic Resonance Unit, University Hospital of Badalona, Barcelona, Spain. giulio.zuccoli@asmn.re.it
Gallucci
M
M
Capellades
J
J
Regnicolo
L
L
Tumiati
B
B
Giadás
T Cabada
TC
Bottari
W
W
Mandrioli
J
J
Bertolini
M
M
D000293:Adolescent; D000328:Adult; D000437:Alcoholism / Q000473:pathology*; D001921:Brain / Q000473:pathology*; D002648:Child; D005260:Female; D006801:Humans; D007558:Italy; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D014899:Wernicke Encephalopathy / Q000473:pathology*
Brain Dev. 1993 Jan-Feb;15(1):67-73
7687829
AJNR Am J Neuroradiol. 1990 Sep-Oct;11(5):887-92
2120991
Arch Neurol. 2000 Sep;57(9):1356-9
10987905
AJNR Am J Neuroradiol. 2005 Feb;26(2):289-97
15709126
AJNR Am J Neuroradiol. 1990 Sep-Oct;11(5):893-4; discussion 895-6
2120992
Lancet. 2000 Apr 22;355(9213):1412-8
10791525
AJNR Am J Neuroradiol. 1990 Jul-Aug;11(4):785-91
2114769
AJNR Am J Neuroradiol. 1994 Jan;15(1):172-4
8141051
Acta Neurol Scand. 1999 Mar;99(3):196-8
10100965
Eur Neurol. 1994;34(3):177-80
8033946
AJNR Am J Neuroradiol. 2003 Aug;24(7):1376-8
12917131
AJNR Am J Neuroradiol. 1995 Apr;16(4):700-2
7611025
Neuroradiology. 1997 Jan;39(1):19-22
9121641
Acta Neurol Scand. 1966;42(4):426-41
5919816
J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):341-5
3701343
AJNR Am J Neuroradiol. 2001 Sep;22(8):1480-2
11559494
Am J Med Sci. 2002 Feb;323(2):107-11
11863078
AJNR Am J Neuroradiol. 1994 Mar;15(3):594-6
8197964
Presse Med. 2002 Nov 23;31(37 Pt 1):1739-45
12489317
Z Neurol. 1973 Aug 29;205(1):1-13
4126735
J Comput Assist Tomogr. 1991 Nov-Dec;15(6):1059-61
1939760
Aust N Z J Med. 1980 Apr;10(2):230-5
6770803
J Comput Assist Tomogr. 1991 Jan-Feb;15(1):160-2
1987190
AJNR Am J Neuroradiol. 2005 Sep;26(8):1986-95
16155147
J Neurol. 1989 Dec;236(8):484-6
2614496
Brain Cogn. 1991 Jan;15(1):69-82
1901211
AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):2005-8
14625223